CardioDynamics Commences Landmark PREVENT-HF Trial Designed By Leading Heart Failure Specialists

Tue, 06 Mar 2007 02:00 PM EST

... CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced commencement of the PREVENT-HF trial, a multinational randomized controlled trial evaluating whether serial BioZ monitoring in chronic heart failure management will delay or prevent heart failure-related hospitalizations compared to standard clinical care. [click link for full article] ...